Tower Research Capital LLC (Trc) Ngm Biopharmaceuticals Inc Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.17 - $1.92 $9,392 - $15,413	-8,028 Reduced 68.72%	3,654 $5,000
Q4 2023 Feb 13, 2024	SELL	$0.6 - $1.31 $9,729 - $21,242	-16,216 Reduced 58.13%	11,682 $10,000
Q3 2023 Nov 14, 2023	BUY	$1.05 - $3.37 $25,042 - $80,374	23,850 Added 589.18%	27,898 $29,000
Q2 2023 Aug 14, 2023	SELL	$2.44 - $4.53 $1,764 - $3,275	-723 Reduced 15.15%	4,048 $10,000
Q1 2023 May 09, 2023	BUY	$3.72 - $5.4 $6,394 - $9,282	1,719 Added 56.32%	4,771 $19,000
Q4 2022 Feb 10, 2023	SELL	$3.41 - $12.93 $8,941 - $33,902	-2,622 Reduced 46.21%	3,052 $16,000
Q3 2022 Nov 10, 2022	BUY	$12.59 - $17.67 $43,322 - $60,802	3,441 Added 154.1%	5,674 $74,000
Q2 2022 Aug 15, 2022	BUY	$10.58 - $17.5 $12,886 - $21,315	1,218 Added 120.0%	2,233 $29,000
Q1 2022 May 12, 2022	BUY	$13.81 - $18.6 $3,852 - $5,189	279 Added 37.91%	1,015 $16,000
Q4 2021 Feb 14, 2022	SELL	$17.26 - $22.02 $94,912 - $121,087	-5,499 Reduced 88.2%	736 $13,000
Q3 2021 Nov 15, 2021	BUY	$20.15 - $26.19 $69,356 - $90,145	3,442 Added 123.24%	6,235 $131,000
Q2 2021 Aug 16, 2021	BUY	$15.06 - $30.03 $16,430 - $32,762	1,091 Added 64.1%	2,793 $55,000
Q1 2021 May 17, 2021	BUY	$24.99 - $31.93 $11,620 - $14,847	465 Added 37.59%	1,702 $49,000
Q4 2020 Feb 16, 2021	SELL	$16.21 - $31.44 $80,288 - $155,722	-4,953 Reduced 80.02%	1,237 $37,000
Q3 2020 Nov 16, 2020	BUY	$15.59 - $19.97 $35,482 - $45,451	2,276 Added 58.15%	6,190 $98,000
Q2 2020 Aug 13, 2020	BUY	$11.97 - $23.47 $31,002 - $60,787	2,590 Added 195.62%	3,914 $77,000
Q1 2020 May 15, 2020	BUY	$10.0 - $19.51 $13,240 - $25,831	1,324 New	1,324 $16,000
Q3 2019 Nov 05, 2019	SELL	$13.09 - $18.19 $14,032 - $19,499	-1,072 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$12.56 - $16.6 $13,464 - $17,795	1,072 New	1,072 $16,000

Others Institutions Holding NGM

# of Institutions

Shares Held

2.6M

Call Options Held

300

Put Options Held

View Full List

About NGM BIOPHARMACEUTICALS INC

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

More about NGM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account